Viatris
- Viatris_MYLAN HEALTHCARE CZ s.r.o._MfE_HCO_Report_2021_Czech.pdf
- Mylan_2019_BGP-Products-Czech-Republic-s.r.o._Disclosure-Tables.pdf
- Viatris_MYLAN HEALTHCARE CZ s.r.o._MfE_HCP Events_Report_2021_Czech.pdf
- Viatris_MYLAN HEALTHCARE CZ s.r.o._MfE_HCP Fees_Report_2021_Czech.pdf
- BGP-Products-CR-Disclosure-2017new-3.pdf
- Viatris_MYLAN PHARMACEUTICALS s.r.o_MfE_HCP_Events_Report_2021_Czech.pdf
- MEDA-Pharma-Disclosure-2017-3.pdf
- Medicines-for-Europe-Disclosure-Tables-CZ_MEDA (1).pdf
- Mylan_2019_MYLAN-PHARMACEUTICALS-s.r.o.-_Disclosure-Tables.pdf
- MYLAN-Pharmaceuticals-Disclosure-2017new-3.pdf
- Viatris_MYLAN PHARMACEUTICALS s.r.o_MfE_HCP_Fees_report_2021_Czech.pdf
- Viatris_MYLAN HEALTHCARE CZ s.r.o._MfE_PO_Report_2021_Czech.pdf
- Medicines-for-Europe-Disclosure-Tables-CZ_MEDA.pdf
- Viatris_MYLAN PHARMACEUTICALS s.r.o_MfE_PO_Report_2021_Czech.pdf
- Medicines-for-Europe-Disclosure-Tables-CZ_BGP.pdf
- Viatris_MYLAN PHARMACEUTICALS s.r.o._MfE_HCO_Report_2021_Czech.pdf